Immunology and Microbiology
Escherichia coli
100%
Adjuvant
100%
Metabolic Engineering
100%
Phosphoryl Lipid A
100%
Gram-Negative Bacteria
20%
Immune Response
10%
Antigen Specificity
10%
Immunotherapy
10%
Immunity
10%
Immunoglobulin G
10%
Outer Membrane
10%
Bacterial Strain
10%
Precursor
10%
Immune System
10%
Drug Hypersensitivity
10%
Keyphrases
Escherichia Coli
100%
Metabolic Engineering
100%
Phosphoinositide Lipid
100%
Gram-negative Bacteria
20%
Engineered E. Coli
20%
Commercially Available
10%
Immune Response
10%
Manufacturing Cost
10%
Antigen-specific
10%
Lipopolysaccharide
10%
Escherichia Coli Strains
10%
Bacterial Strains
10%
Immune System
10%
IgG Antibody
10%
Outer Membrane
10%
Synthetic Routes
10%
Manufacturing Time
10%
In Situ Production
10%
Chemical Transformation
10%
Synthetic Chemicals
10%
GlaxoSmithKline
10%
Merck
10%
Vaccine Allergy
10%